Tukaram Mundhe Vimal Notice: Can Maharashtra FDA hold Shah Rukh Khan, Ajay Devgn, Tiger Shroff responsible?

The Maharashtra Meals and Drug Administration’s (FDA’s) motion towards actors Shah Rukh Khan, Ajay Devgn and Tiger Shroff over a Vimal Elaichi advertisement has thrown up an enormous query. How far can a state-level meals regulatory authority go in holding celebrities accountable for the promotion of a product that it alleges is getting used to not directly promote a banned pan masala?

Is not surrogate promoting a website of client safety our bodies and their allied legal guidelines? Or ought to they be addressed by the legal guidelines governing tobacco merchandise within the case of pan masala?

The three actors have been issued show-cause notices by the Maharashtra FDA on Sunday (August 16). The allegation is that their Vimal Elaichi commercial quantities to surrogate promoting for Vimal Pan Masala, which the FDA describes as a product prohibited within the state. The Vimal model is understood for the catchphrase ‘Bolo Zubaan Kesari‘ to promote its pan masala and elaichi (cardamom).

India In the present day Digital spoke to legal professionals from the Supreme Courtroom and the Bombay Excessive Courtroom to look at whether or not the Maharashtra FDA has the authorized authority to take motion towards the three people—Shah Rukh Khan, Ajay Devgn and Tiger Shroff — in such instances.

The FDA has cited Sections 24 and 53 of the Meals Security and Requirements (FSS) Act, 2006, which prohibit deceptive meals ads and penalise these concerned of their publication. Part 53 gives for a penalty of as much as Rs 10 lakh for anybody “celebration to the publication”. The discover additionally requested the actors to elucidate their roles, cease endorsing Vimal Pan Masala/Elaichi, take away promotional content material from their social media handles and stop additional promotion.

The actors have been given 15 days to reply with written explanations and supporting paperwork.

The motion comes at a time when Maharashtra’s FDA, underneath Commissioner Tukaram Mundhe, has stepped up enforcement towards food-safety violations and prohibited merchandise. The FDA underneath Mundhe has raided quite a few meals institutions and earned public praise for tough action against irregularities.

An advocate of the Supreme Courtroom of India, who’s conversant in the case and has intently adopted the proceedings, instructed India In the present day Digital, “The FDA would first want to ascertain the precise statutory foundation underneath which it’s continuing towards these celebrities.” The advocate requested anonymity.

A latest LocalCircles survey of greater than 37,000 shoppers throughout 297 districts discovered that 64% had seen surrogate chewing tobacco ads, whereas 76% needed manufacturers to declare that no affiliated entity was not directly promoting them. Individually, 84% of 12,341 respondents mentioned they’d encountered deceptive or false celeb ads, discovered one other survey by LocalCircles, a group and social media platform.

CAN THE FDA ACT AGAINST CELEBRITIES OVER VIMAL ELAICHI ADS?

The Maharashtra FDA is inside its authorized authority to challenge show-cause notices to celebrities over their alleged involvement in surrogate ads for a pan masala model prohibited in Maharashtra, Bombay Excessive Courtroom advocate Sankalpa Rajpurohit instructed India In the present day Digital.

However the legalities on this case are extra nuanced.

The notices issued to Shah Rukh Khan, Ajay Devgn and Tiger Shroff are primarily based on provisions of the FSS Act.

It was enacted in 2006 to put down “science-based requirements for articles of meals” and regulate their “manufacture, storage, distribution, sale and import.” Its central function is to make sure the supply of “secure and healthful meals for human consumption.” The Act additionally established the FSSAI, India’s food-safety regulator.

Rajpurohit mentioned the operative provision is Part 53 of the FSS Act, 2006. “Part 53 penalises any one who publishes, or is a celebration to the publication of, a deceptive meals commercial,” he mentioned.

Nonetheless, Rajpurohit clarified that the FDA itself can not levy the Rs 10-lakh penalty. “The penalty can solely be imposed by an Adjudicating Officer of at the least the rank of Further District Justice of the Peace underneath Part 68 [FSS Act, 2006],” he mentioned, including that the order will be challenged earlier than the Meals Security Appellate Tribunal.

Additionally, the Meals Security Act doesn’t particularly point out endorsers or model ambassadors, not like the Shopper Safety Act, which clearly defines an “endorser”. Treating an actor as “a celebration to the publication” is a doable interpretation of the legislation, nevertheless it is not a settled one. On this case, the FDA is testing a authorized argument somewhat than counting on a longtime one.

Bombay-based advocate Rajpurohit emphasised that whereas there are these authorized technicalities, you will need to keep in mind that the discover is just a show-cause discover.

India In the present day Digital approached Santosh Kamble, Joint Commissioner, Meals, FDA Mumbai, for remark, however didn’t obtain a response. The story will probably be up to date as and when he responds.

MULTIPLE LAWS CAN OPERATE SIMULTANEOUSLY IN CASE OF SURROGATE ADS

Addressing the jurisdictional framework, Rajpurohit emphasised that within the case of surrogate promoting, a number of statutory our bodies can function concurrently. It could subsequently contain a number of legal guidelines, together with the Shopper Safety Act, 2019, underneath which the Central Shopper Safety Authority (CCPA) features, and the Cigarettes and Different Tobacco Merchandise Act (COTPA), which regulates tobacco merchandise in India, together with prohibition, promoting and sale.

So, can motion underneath one legislation stop one other regulator from stepping in? Rajpurohit mentioned that’s not how the framework works.

“There’s an overlap — the Shopper Safety Act operates along with, and never in derogation of, different legal guidelines, so each the FDA and the CCPA can proceed. The FSS Act’s overriding impact applies solely to different meals legal guidelines, so it would not displace the CCPA. What the FDA has achieved is select the statute it really administers,” Rajpurohit instructed India In the present day Digital.

The lawyer additionally mentioned the notices issued to Shah Rukh Khan, Ajay Devgn and Tiger Shroff are primarily based on provisions regarding individuals who publish or are celebration to the publication of an commercial. He added, “Anybody who publishes, or is a celebration to the publication of, a deceptive meals commercial is liable underneath Part 53 of the FSS Act.”

The FDA, Rajpurohit mentioned, could be looking for details about the actors’ involvement within the ads, together with their contracts and whether or not they knew the ads may operate as surrogates for banned merchandise. The present notices may subsequently serve primarily as a fact-finding train.

FDA CAN’T ORDER SHAH RUKH, AJAY, TIGER TO TAKE DOWN SOCIAL MEDIA POSTS

In the identical discover, the FDA has laid out eight factors it expects the three actors to behave on instantly. Amongst them is “instantly eradicating the commercial and promotional content material from their social media handles.”

Nonetheless, Rajpurohit drew a line between the FDA’s regulatory powers and the facility to order social-media takedowns. Requested whether or not the FDA may direct celebrities to take away all posts, he mentioned, “They’ll ask for a takedown. They can’t order, and so they actually can not order each publish. The Meals Security Act’s response to a deceptive commercial is a penalty… not an administrative takedown.”

“Each coercive promoting treatment in that framework [the food safety framework] runs towards meals enterprise operators and is enforced by way of the licence, and an actor would not maintain a licence. The facility to direct discontinuance of an commercial does exist in Indian legislation — it is Part 21 of the Shopper Safety Act, and it belongs to the CCPA,” Bombay Excessive Courtroom advocate Sankalpa Rajpurohit defined.

It should be famous that direct blocking/takedown orders of on-line content material fall underneath Part 69A of the Data Expertise (IT) Act, 2000, executed by designated central officers, or by way of courtroom orders. The FSSAI or the FDA just isn’t an authorised blocking company underneath the IT Act.

“So the discover is on agency floor on who it targets, and on shakier floor on what it directs,” the Bombay Excessive Courtroom advocate additionally mentioned.

SHOULD MUNDHE’S FDA HAVE QUESTIONED VIMAL INSTEAD OF ACTORS ENDORSING THE BRAND?

The FDA’s allegation hinges on the concept of surrogate promoting.

Surrogate promoting is mostly understood as a state of affairs the place a model related to a restricted or prohibited product promotes one other product underneath the identical or a intently related model id, successfully conserving the prohibited product seen to shoppers.

To find out if an commercial is surrogate in nature, regulators may have a look at elements such because the branding, packaging, slogans and visible id used, the celebrities related to it, and the way intently the marketed product is linked to the prohibited one.

The Supreme Courtroom advocate, who spoke to India In the present day Digital looking for anonymity, defined, “As a substitute of issuing notices to the celebrities, the FDA ought to first have sought an evidence, and supporting proof from Vimal. If the allegation is that Vimal Elaichi is merely a surrogate for pan masala, then the producer is in the most effective place to ascertain whether or not the elaichi is definitely being bought and marketed as a standalone product. What data would Shah Rukh Khan, Ajay Devgn or Tiger Shroff have concerning the firm’s gross sales or distribution?”

The excellence is especially necessary as a result of Maharashtra has prohibited the manufacture, storage, distribution, transportation and sale of gutkha and pan masala containing tobacco or nicotine and several other related tobacco- and areca-nut products underneath its food-safety powers.

“The Maharashtra FDA’s jurisdiction is restricted to Maharashtra, the place pan masala merchandise containing tobacco have already been prohibited for years. So what precisely is the aim of this discover? If the target is to cease the promotion of a prohibited product, it additionally raises the query whether or not such a product is continuous to be bought within the state regardless of the prohibition. If that’s occurring, the discover inevitably places the highlight again on the enforcement authorities and their means to implement an order that has been in place for years,” the Supreme Courtroom advocate added.

WHY TARGET FACE OF THE PRODUCT INSTEAD OF THE BANNED PRODUCT?

However the notices additionally increase the query: why goal the face of the commercial, Shah Rukh Khan, Ajay Devgn and Tiger Shroff on this case, whereas leaving the bigger enforcement failure largely unaddressed?

“If the FDA is saying {that a} celeb’s commercial is selling a prohibited pan masala, then the plain query is how is that prohibited product reaching the market within the first place?” the Supreme Courtroom advocate requested, looking for anonymity.

“The discover, in that sense, raises questions on enforcement as a lot because it raises questions concerning the celebrities. If the product has been banned in Maharashtra for years however continues to be promoted or bought, that factors to a failure of enforcement that can’t merely be shifted onto the celebrities,” the Supreme Courtroom advocate added.

So, the FDA looking for explanations from the celebrities is nicely inside its ambit, however different legal guidelines and questions additionally come into play when coping with a pan masala model that has confronted scrutiny previously but gone largely unscathed.

Because the Bombay Excessive Courtroom advocate urged, the notices may additionally be a option to get to the basis of the alleged surrogate promoting. Nonetheless, directives comparable to taking down social media posts transcend what the FDA can order, and are within the gray zone.

– Ends

Printed By:

Anand Singh

Printed On:

Aug 19, 2026 07:00 IST

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *